Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis.

• Egile Nagusiak: Rachel S Laufer (Egilea), Ranju Baral (Egilea), Andrea G Buchwald (Egilea), James D Campbell (Egilea), Flanon Coulibaly (Egilea), Fatoumata Diallo (Egilea), Moussa Doumbia (Egilea), Amanda J Driscoll (Egilea), Alison P Galvani (Egilea), Adama M Keita (Egilea), Kathleen M Neuzil (Egilea), Samba Sow (Egilea), Clint Pecenka (Egilea), Justin R Ortiz (Egilea), Meagan C Fitzpatrick (Egilea)
• Formatua: Liburua
• Argitaratua: Public Library of Science (PLoS), 2023-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Respiratory syncytial virus (RSV) is the most common cause of early childhood lower respiratory tract infection (LRTI) in low- and middle-income countries (LMICs). Maternal vaccines, birth-dose extended half-life monoclonal antibodies (mAbs), and pediatric vaccines are under development for preventi...